Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Exercise / conversionWarrant (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · derivative · entry 9 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2025-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Tax withholdingCommon Stock | 75 | $29.05 | $2,178.75 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · nonDerivative · entry 8 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,256 Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Exercise / conversionCommon Stock | 600 | $3.63 | $2,178.00 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · nonDerivative · entry 7 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Tax withholdingCommon Stock | 56 | $29.05 | $1,626.80 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · nonDerivative · entry 6 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,731 Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Exercise / conversionCommon Stock | 450 | $3.63 | $1,633.50 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · nonDerivative · entry 5 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Tax withholdingCommon Stock | 19 | $29.05 | $551.95 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · nonDerivative · entry 4 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,337 Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Exercise / conversionCommon Stock | 150 | $3.63 | $544.50 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · nonDerivative · entry 3 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Tax withholdingCommon Stock | 1,429 | $29.05 | $41,512.45 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · nonDerivative · entry 2 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,206 Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:23 UTC |
McNeill LarryDirector
|
Exercise / conversionCommon Stock | 50,000 | $0.83 | $41,500.00 |
DisclosureSEC source: 0001663577-21-000010 · ownership.xml · nonDerivative · entry 1 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:24 UTC |
Bradford ZacharyDirector · CEO and President
|
Exercise / conversionWarrant (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001663577-21-000012 · ownership.xml · derivative · entry 3 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:24 UTC |
Bradford ZacharyDirector · CEO and President
|
Tax withholdingCommon Stock | 715 | $29.05 | $20,770.75 |
DisclosureSEC source: 0001663577-21-000012 · ownership.xml · nonDerivative · entry 2 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,980 F1 · balance_after: Includes 323,864 shares of common stock held in ZRB Holdings Inc. in which Mr. Bradford is the beneficial owner, 12,000 shares of common stock held in BlueChip Advisors LLC in which Mr. Bradford shares beneficial ownership, and 203,116 shares of common stock held in his name. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:24 UTC |
Bradford ZacharyDirector · CEO and President
|
Exercise / conversionCommon Stock | 25,000 | $0.83 | $20,750.00 |
DisclosureSEC source: 0001663577-21-000012 · ownership.xml · nonDerivative · entry 1 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 17:10 UTC |
Beynon Roger PaulDirector
|
GrantCommon Stock | 740 | $10.13 | $7,496.20 |
DisclosureSEC source: 0001663577-20-000510 · ownership.xml · nonDerivative · entry 1 Beynon Roger Paul · CIK 0001790906 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,695 F1 · shares: On December 22, 2020, Mr. Beynon was issued 740 shares of common stock as compensation for his services as a director of the issuer. As provided in his compensation, Mr. Beynon shall be issued shares of common stock at the price per share of such common stock on the 1st day of each month of service beginning October 1, 2020. F2 · price: The price reported in column 4 is a weighted average price. These shares were issued in multiple transactions valued as of the closing price on the first day of each month at price ranging from $7.73 to $12.43 per share. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 22:11 UTC |
Wood Thomas LeighDirector
|
GrantCommon Stock | 740 | $10.13 | $7,496.20 |
DisclosureSEC source: 0001663577-20-000512 · ownership.xml · nonDerivative · entry 1 Wood Thomas Leigh · CIK 0001791225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,700 F1 · shares: On December 22, 2020, Mr. Wood was issued 740 shares of common stock as compensation for his services as a director of the issuer. As provided in his compensation, Mr. Wood shall be issued shares of common stock at the price per share of such common stock on the 1st day of each month of service beginning October 1, 2020. F2 · price: The price reported in column 4 is a weighted average price. These shares were issued in multiple transactions valued as of the closing price on the first day of each month at price ranging from $7.73 to $12.43 per share. F3 · balance_after: Mr. Wood's beneficial ownership includes indirect ownership of 45,196 shares of the issuer's common stock held by his wife. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 01:00 UTC |
Tadayon AmerChief Revenue Officer
|
GrantStock Option (Righ to Buy) · Derivative | 30,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000399 · ownership.xml · derivative · entry 1 Tadayon Amer · CIK 0001802500 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2023-10-25 F1 · derivative.exercise_date: The Options shall vest ratably over a 12 month period commencing on the vesting commencement date of October 1, 2020 (the "Vesting Start Date") as follows: 1/12 upon each of month anniversary of the Vesting Start Date, (such that 100% of the Options shall be vested as of the anniversary of the Vesting Start Date), provided that reporting person is employed by the issuer on each such vesting date. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:59 UTC |
Kabak AmandaChief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000397 · ownership.xml · derivative · entry 4 Kabak Amanda · CIK 0001793969 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2023-10-25 F4 · derivative.exercise_date: On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 20,000 shares of common stock to Ms. Kabak under the issuer's equity incentive plan which options vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The options were granted with an exercise price of $9.00 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:59 UTC |
Kabak AmandaChief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000397 · ownership.xml · derivative · entry 3 Kabak Amanda · CIK 0001793969 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2023-10-25 F3 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 5,000 shares of common stock to Ms. Kabak under the issuer's equity incentive plan as a bonus for fiscal year 2020 ended September 30, 2020. The options were fully vested on grant and were granted at an exercise price of $9.00 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:59 UTC |
Kabak AmandaChief Technology Officer
|
GrantCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-20-000397 · ownership.xml · nonDerivative · entry 2 Kabak Amanda · CIK 0001793969 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 F2 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 15,000 shares of restricted common stock to Ms. Kabak under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 15,000 shares of restricted common stock to Ms. Kabak under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:59 UTC |
Kabak AmandaChief Technology Officer
|
GrantCommon Stock | 13,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-20-000397 · ownership.xml · nonDerivative · entry 1 Kabak Amanda · CIK 0001793969 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F1 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 13,000 shares of common stock to Ms. Kabak under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F1 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 13,000 shares of common stock to Ms. Kabak under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:56 UTC |
Bradford ZacharyDirector · CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000391 · ownership.xml · derivative · entry 4 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2023-10-25 F5 · derivative.exercise_date: On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 30,000 shares of common stock to Mr. Bradford under the issuer's equity incentive plan which options vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The options were granted with an exercise price of $9.00 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:56 UTC |
Bradford ZacharyDirector · CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000391 · ownership.xml · derivative · entry 3 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2023-10-25 F4 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 25,000 shares of common stock to Mr. Bradford under the issuer's equity incentive plan as a bonus for fiscal year 2020 ended September 30, 2020. The options were fully vested on grant and were granted with an exercise price of $9.00 per share Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:56 UTC |
Bradford ZacharyDirector · CEO and President
|
GrantCommon Stock | 69,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-20-000391 · ownership.xml · nonDerivative · entry 2 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484,695 F3 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 69,000 shares of restricted common stock to Mr. Bradford under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F3 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 69,000 shares of restricted common stock to Mr. Bradford under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · balance_after: In addition to the stock grants disclosed on this Form 4, this includes 323,864 shares of common stock held in ZRB Holdings Inc. in which Mr. Bradford is the beneficial owner, 12,000 shares of common stock held in BlueChip Advisors LLC in which Mr. Bradford shares beneficial ownership, and 4,831 shares of common stock held in his name. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:56 UTC |
Bradford ZacharyDirector · CEO and President
|
GrantCommon Stock | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-20-000391 · ownership.xml · nonDerivative · entry 1 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,695 F1 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 75,000 shares of common stock to Mr. Bradford under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F1 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 75,000 shares of common stock to Mr. Bradford under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · balance_after: In addition to the stock grants disclosed on this Form 4, this includes 323,864 shares of common stock held in ZRB Holdings Inc. in which Mr. Bradford is the beneficial owner, 12,000 shares of common stock held in BlueChip Advisors LLC in which Mr. Bradford shares beneficial ownership, and 4,831 shares of common stock held in his name. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:58 UTC |
Schultz S. MatthewDirector · Executive Chairman
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000395 · ownership.xml · derivative · entry 4 Schultz S. Matthew · CIK 0001625587 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2023-10-25 F5 · derivative.exercise_date: On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 24,000 shares of common stock to Mr. Schultz under the issuer's equity incentive plan which options vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The options were granted with an exercise price of $9.00 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:58 UTC |
Schultz S. MatthewDirector · Executive Chairman
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000395 · ownership.xml · derivative · entry 3 Schultz S. Matthew · CIK 0001625587 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2023-10-25 F4 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 20,000 shares of common stock to Mr. Schultz under the issuer's equity incentive plan as a bonus for fiscal year 2020 ended September 30, 2020. The options were fully vested on grant and were granted at an exercise price of $9.00 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:58 UTC |
Schultz S. MatthewDirector · Executive Chairman
|
GrantCommon Stock | 55,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-20-000395 · ownership.xml · nonDerivative · entry 2 Schultz S. Matthew · CIK 0001625587 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 660,996 F3 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 55,000 shares of restricted common stock to Mr. Schultz under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F3 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 55,000 shares of restricted common stock to Mr. Schultz under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · balance_after: In addition to the stock grants disclosed on this Form 4, this includes 480,000 shares of common stock held in the S M Schultz IRRV TR to which Mr. Schultz is the beneficial owner, 25,000 shares of common stock held in his name and 40,996 shares of common stock held by his spouse. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:58 UTC |
Schultz S. MatthewDirector · Executive Chairman
|
GrantCommon Stock | 60,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-20-000395 · ownership.xml · nonDerivative · entry 1 Schultz S. Matthew · CIK 0001625587 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605,996 F1 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 60,000 shares of common stock to Mr. Schultz under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F1 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 60,000 shares of common stock to Mr. Schultz under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · balance_after: In addition to the stock grants disclosed on this Form 4, this includes 480,000 shares of common stock held in the S M Schultz IRRV TR to which Mr. Schultz is the beneficial owner, 25,000 shares of common stock held in his name and 40,996 shares of common stock held by his spouse. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:57 UTC |
Love LoriChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000393 · ownership.xml · derivative · entry 4 Love Lori · CIK 0001790902 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2023-10-25 F4 · derivative.exercise_date: On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 10,000 shares of common stock to Ms. Love under the issuer's equity incentive plan which options vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The options were granted with an exercise price of $9.00 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:57 UTC |
Love LoriChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000393 · ownership.xml · derivative · entry 3 Love Lori · CIK 0001790902 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2023-10-25 F3 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 12,500 shares of common stock to Ms. Love under the issuer's equity incentive plan as a bonus for fiscal year 2020 ended September 30, 2020. The options were fully vested on grant and were granted at an exercise price of $9.00 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:57 UTC |
Love LoriChief Financial Officer
|
GrantCommon Stock | 13,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-20-000393 · ownership.xml · nonDerivative · entry 2 Love Lori · CIK 0001790902 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,081 F2 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 13,250 shares of restricted common stock to Ms. Love under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 13,250 shares of restricted common stock to Ms. Love under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:57 UTC |
Love LoriChief Financial Officer
|
GrantCommon Stock | 38,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-20-000393 · ownership.xml · nonDerivative · entry 1 Love Lori · CIK 0001790902 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,831 F1 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 38,000 shares of common stock to Ms. Love under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F1 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 38,000 shares of common stock to Ms. Love under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. Read SEC document |
| October 26, 2020 Filed Jan 6, 2021 02:21 UTC Amendment |
Bradford ZacharyDirector · CEO and President
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-21-000008 · ownership.xml · nonDerivative · entry 1 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,695 F1 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 30,000 shares of restricted common stock to Mr. Bradford under the issuer's equity incentive plan which shares vest monthly over fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · shares: The original Form 4, filed on October 28, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which failed to include the grant of 30,000 shares of restricted stock referenced herein. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 30,000 shares. F1 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 30,000 shares of restricted common stock to Mr. Bradford under the issuer's equity incentive plan which shares vest monthly over fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F3 · balance_after: Includes 323,864 shares of common stock held in ZRB Holdings Inc. in which Mr. Bradford is the beneficial owner, 12,000 shares of common stock held in BlueChip Advisors LLC in which Mr. Bradford shares beneficial ownership, and 178,831 shares of common stock held in his name. Read SEC document |
| October 26, 2020 Filed Jan 6, 2021 02:20 UTC Amendment |
Schultz S. MatthewDirector · Executive Chairman
|
GrantCommon Stock | 24,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-21-000006 · ownership.xml · nonDerivative · entry 1 Schultz S. Matthew · CIK 0001625587 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,996 F1 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 24,000 shares of restricted common stock to Mr. Schultz under the issuer's equity incentive plan which shares vest monthly over fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · shares: The original Form 4, filed on October 28, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which failed to include the grant of 24,000 shares of restricted stock referenced herein. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 24,000 shares. F1 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 24,000 shares of restricted common stock to Mr. Schultz under the issuer's equity incentive plan which shares vest monthly over fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F3 · balance_after: Includes 480,000 shares of common stock held in the S M Schultz IRRV TR to which Mr. Schultz is the beneficial owner, 164,000 shares of common stock held in his name and 40,996 shares of common stock held by his spouse. Read SEC document |
| October 26, 2020 Filed Jan 6, 2021 02:16 UTC Amendment |
Kabak AmandaChief Technology Officer
|
GrantCommon Stock | 7,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-21-000004 · ownership.xml · nonDerivative · entry 1 Kabak Amanda · CIK 0001793969 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 7,000 shares of restricted common stock to Ms. Kabak under the issuer's equity incentive plan which shares vest monthly over fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · shares: The original Form 4, filed on October 28, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which failed to include the grant of 7,000 shares of restricted stock referenced herein. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 7,000 shares. F1 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 7,000 shares of restricted common stock to Ms. Kabak under the issuer's equity incentive plan which shares vest monthly over fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. Read SEC document |
| October 26, 2020 Filed Jan 6, 2021 02:15 UTC Amendment |
Love LoriChief Financial Officer
|
GrantCommon Stock | 9,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001663577-21-000002 · ownership.xml · nonDerivative · entry 1 Love Lori · CIK 0001790902 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,081 F1 · shares: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 9,000 shares of restricted common stock to Ms. Love under the issuer's equity incentive plan which shares vest monthly over fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. F2 · shares: The original Form 4, filed on October 28, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which failed to include the grant of 9,000 shares of restricted stock referenced herein. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 9,000 shares. F1 · price: On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 9,000 shares of restricted common stock to Ms. Love under the issuer's equity incentive plan which shares vest monthly over fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 21:14 UTC |
Beynon Roger PaulDirector
|
GrantCommon Stock | 1,681 | $4.46 | $7,497.26 |
DisclosureSEC source: 0001663577-20-000358 · ownership.xml · nonDerivative · entry 1 Beynon Roger Paul · CIK 0001790906 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,955 F1 · shares: On September 29, 2020, Mr. Beynon was issued 1,681 shares of common stock as compensation for his services as a director of the issuer for the past three months. As provided in his compensation agreement, Mr. Beynon shall earn $2,500 of common stock calculated at the price per share of such common stock on the 1st day of each month of service. The measurement dates were July 1, 2020, August 3rd and September 1st. Under the terms of the agreement the shares are to be issued quarterly. F2 · price: The price reported in column 4 is a weighted average price. These shares were issued in multiple transactions valued as of the closing price on the first day of each month at price ranging from $2.36 to $10.37 per share. Read SEC document |
| September 28, 2020 Filed Oct 1, 2020 01:13 UTC |
Wood Thomas LeighDirector
|
GrantCommon Stock | 1,681 | $4.46 | $7,497.26 |
DisclosureSEC source: 0001663577-20-000357 · ownership.xml · nonDerivative · entry 1 Wood Thomas Leigh · CIK 0001791225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,960 F1 · shares: On September 29, 2020, Mr. Wood was issued 1,681 shares of common stock as compensation for his services as a director of the issuer for the past three months. As provided in his compensation agreement, Mr. Wood shall earn $2,500 of common stock calculated at the price per share of such common stock on the 1st day of each month of service. The measurement dates were July 1, 2020, August 3rd and September 1st. Under the terms of the agreement the shares are to be issued quarterly. F2 · price: The price reported in column 4 is a weighted average price. These shares were issued in multiple transactions valued as of the closing price on the first day of each month at price ranging from $2.36 to $10.37 per share. F3 · balance_after: Mr. Wood's beneficial ownership includes indirect ownership of 45,196 shares of the issuer's common stock held by his wife. Read SEC document |
| August 19, 2020 Filed Nov 13, 2020 21:30 UTC |
McNeill LarryDirector
|
GiftCommon Stock | 6,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001663577-20-000420 · ownership.xml · nonDerivative · entry 1 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,635 F1 · ownership.direct: Includes 42,000 shares of common stock held in his name and 71,635 shares of common stock held in his Roth IRA Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 16:24 UTC |
Beynon Roger PaulDirector
|
GrantCommon Stock | 8,274 | $2.72 | $22,505.28 |
DisclosureSEC source: 0001663577-20-000180 · ownership.xml · nonDerivative · entry 1 Beynon Roger Paul · CIK 0001790906 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,274 F1 · shares: On June 23, 2020, Mr. Beynon was issued 8,274 shares of common stock as compensation for his services as a director of the issuer. As provided in his compensation, Mr. Beynon shall be issued shares of common stock at the price per share of such common stock on the 1st day of each month of service beginning October 1, 2019. F2 · price: The price reported in column 4 is a weighted average price. These shares were issued in multiple transactions valued as of the closing price on the first day of each month at price ranging from $1.16 to $8.50 per share. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:28 UTC |
Bradford ZacharyDirector · CEO and President
|
GrantCommon Stock | 4,831 | $2.07 | $10,000.17 |
DisclosureSEC source: 0001663577-20-000184 · ownership.xml · nonDerivative · entry 1 Bradford Zachary · CIK 0001625557 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,694 F1 · shares: On June 23, 2020, the board of directors of the issuer approved an issuance of common stock to Mr. Bradford as payment for deferred compensation owed to Mr. Bradford in the amount of $10,000. The shares were issued at the closing bid price of common stock of the issuer on June 22, 2020 of $2.07. F2 · balance_after: Includes 323,863 shares of common stock held in ZRB Holdings Inc. in which Mr. Bradford is the beneficial owner and 12,000 shares of common stock held in BlueChip Advisors LLC in which Mr. Bradford shares beneficial ownership. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:27 UTC |
Love LoriChief Financial Officer
|
GrantCommon Stock | 4,831 | $2.07 | $10,000.17 |
DisclosureSEC source: 0001663577-20-000182 · ownership.xml · nonDerivative · entry 1 Love Lori · CIK 0001790902 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,831 F1 · shares: On June 23, 2020, the board of directors of the issuer approved an issuance of common stock to Ms. Love as payment for deferred compensation owed to Ms. Love in the amount of $10,000. The shares were issued at the closing bid price of common stock of the issuer on June 22, 2020 of $2.07. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:23 UTC |
Wood Thomas LeighDirector
|
GrantCommon Stock | 7,083 | $2.12 | $15,015.96 |
DisclosureSEC source: 0001663577-20-000178 · ownership.xml · nonDerivative · entry 1 Wood Thomas Leigh · CIK 0001791225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,279 F1 · shares: On June 23, 2020, Mr. Wood was issued 7,083 shares of common stock as compensation for his services as a director of the issuer. As provided in his compensation, Mr. Wood shall be issued shares of common stock at the price per share of such common stock on the 1st day of each month of service beginning January 1, 2020. F2 · price: The price reported in column 4 is a weighted average price. These shares were issued in multiple transactions valued as of the closing price on the first day of each month at price ranging from $1.16 to $5.40 per share. F3 · balance_after: Mr. Wood's beneficial ownership includes indirect ownership of 45,196 shares of the issuer's common stock held by his wife. Read SEC document |
| January 31, 2020 Filed Feb 6, 2020 21:45 UTC |
Tadayon AmerChief Revenue Officer
|
GrantCommon Stock | 64,516 | $4.65 | $299,999.40 |
DisclosureSEC source: 0001663577-20-000030 · ownership.xml · nonDerivative · entry 2 Tadayon Amer · CIK 0001802500 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,699 Read SEC document |
| January 31, 2020 Filed Feb 6, 2020 21:45 UTC |
Tadayon AmerChief Revenue Officer
|
GrantCommon Stock | 31,183 | $4.65 | $145,000.95 |
DisclosureSEC source: 0001663577-20-000030 · ownership.xml · nonDerivative · entry 1 Tadayon Amer · CIK 0001802500 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,183 Read SEC document |
| January 31, 2020 Filed Nov 13, 2020 21:28 UTC |
Tadayon AmerChief Revenue Officer
|
GrantStock Option (Righ to Buy) · Derivative | 30,000 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001663577-20-000418 · ownership.xml · derivative · entry 1 Tadayon Amer · CIK 0001802500 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2023-01-30 F1 · derivative.exercise_date: The Options are fully vested on the date of grant. Read SEC document |
| December 20, 2019 Filed Dec 27, 2019 02:47 UTC |
Kabak AmandaChief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 21,231 | $0.00 Strike: $5.60 | $0.00 |
DisclosureSEC source: 0001663577-19-000447 · ownership.xml · derivative · entry 2 Kabak Amanda · CIK 0001793969 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,231 Underlying: Common Stock · 21,231 shares Expires 2022-12-20 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments beginning on the date of grant. Read SEC document |
| December 20, 2019 Filed Dec 27, 2019 02:47 UTC |
Kabak AmandaChief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001663577-19-000447 · ownership.xml · derivative · entry 1 Kabak Amanda · CIK 0001793969 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,359 Underlying: Common Stock · 8,725 shares Expires not disclosed F1 · derivative.exercise_price: The reporting person is entitled to $100,000 of options per year, which are granted monthly at the fair market value on date of each monthly grant. The options are fully vested upon grant and expire three years from date of grant. The exercise price of the options ranges from $6.40-$46.00 per share. F1 · derivative.exercise_date: The reporting person is entitled to $100,000 of options per year, which are granted monthly at the fair market value on date of each monthly grant. The options are fully vested upon grant and expire three years from date of grant. The exercise price of the options ranges from $6.40-$46.00 per share. F1 · derivative.expiration_date: The reporting person is entitled to $100,000 of options per year, which are granted monthly at the fair market value on date of each monthly grant. The options are fully vested upon grant and expire three years from date of grant. The exercise price of the options ranges from $6.40-$46.00 per share. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:09 UTC |
McNeill LarryDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.60 | $0.00 |
DisclosureSEC source: 0001663577-19-000442 · ownership.xml · derivative · entry 1 McNeill Larry · CIK 0001636183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-12-20 F1 · derivative.exercise_date: The option shares are fully vested as of the date of grant. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:11 UTC |
Love LoriChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.60 | $0.00 |
DisclosureSEC source: 0001663577-19-000444 · ownership.xml · derivative · entry 1 Love Lori · CIK 0001790902 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-12-20 F1 · derivative.exercise_date: The option shares are fully vested as of the date of grant. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:06 UTC |
Schultz S. MatthewDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.60 | $0.00 |
DisclosureSEC source: 0001663577-19-000438 · ownership.xml · derivative · entry 1 Schultz S. Matthew · CIK 0001625587 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-12-20 F1 · derivative.exercise_date: The option shares are fully vested as of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.